Pelage Pharmaceuticals, Inc.
Funding history
About Pelage Pharmaceuticals, Inc.
How much funding has Pelage Pharmaceuticals, Inc. raised?
Pelage Pharmaceuticals, Inc. has raised $134.0M in total funding. The most recent round was Series B.
Where is Pelage Pharmaceuticals, Inc. headquartered?
Pelage Pharmaceuticals, Inc. is headquartered in Los Angeles, CA.
What problem does Pelage Pharmaceuticals, Inc. solve?
Existing hair loss treatments like minoxidil and PRP have limited efficacy and unclear mechanisms, target only secondary factors such as hormones, and no new FDA-approved options have emerged in almost three decades.
What's Pelage Pharmaceuticals, Inc.'s solution?
Pelage is developing PP405, a topically-applied small molecule designed to reactivate dormant hair follicle stem cells and regrow hair.
What makes Pelage Pharmaceuticals, Inc. different?
The approach is based on UCLA scientists' discovery of a metabolic switch that activates hair follicle stem cells, is non-hormonal and designed for all genders and hair types, and is applied topically without detectable systemic exposure.
What makes Pelage Pharmaceuticals, Inc. notable?
Pelage raised a $120 million Series B co-led by ARCH Venture Partners and Google's venture arm GV, with GV's Cathy Friedman appointed board chair.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.